skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Amplifying the Red-Emission of Upconverting Nanoparticles for Biocompatible Clinically Used Prodrug-Induced Photodynamic Therapy

Abstract

A class of biocompatible upconverting nanoparticles (UCNPs) with largely amplified red-emissions was developed. The optimal UCNP shows a high absolute upconversion quantum yield of 3.2% in red-emission, which is 15-fold stronger than the known optimal β-phase core/shell UCNPs. When conjugated to aminolevulinic acid, a clinically used photodynamic therapy (PDT) prodrug, significant PDT effect in tumor was demonstrated in a deep-tissue (>1.2 cm) setting in vivo at a biocompatible laser power density. Furthermore, we show that our UCNP–PDT system with NIR irradiation outperforms clinically used red light irradiation in a deep tumor setting in vivo. This study marks a major step forward in photodynamic therapy utilizing UCNPs to effectively access deep-set tumors.Lastly, it also provides an opportunity for the wide application of upconverting red radiation in photonics and biophotonics.

Authors:
 [1];  [2];  [1];  [1];  [1];  [1];  [3];  [3];  [4];  [5];  [1]
  1. Univ. of Massachusetts, Amherst, MA (United States)
  2. Univ. of Massachusetts, Amherst, MA (United States); Dalian Univ. of Technology, Dalian (China)
  3. Soochow Univ., Suzhou, Jiangsu (China)
  4. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Molecular Foundry
  5. Dalian Univ. of Technology, Dalian (China)
Publication Date:
Research Org.:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22)
OSTI Identifier:
1257361
Grant/Contract Number:  
AC02-05CH11231; R01MH103133; RGY0090/2014
Resource Type:
Accepted Manuscript
Journal Name:
ACS Nano
Additional Journal Information:
Journal Volume: 8; Journal Issue: 10; Journal ID: ISSN 1936-0851
Publisher:
American Chemical Society
Country of Publication:
United States
Language:
English
Subject:
77 NANOSCIENCE AND NANOTECHNOLOGY; upconverting; nanoparticles; red-emission; prodrug; photodynamic therapy

Citation Formats

Punjabi, Amol, Wu, Xiang, Tokatli-Apollon, Amira, El-Rifai, Mahmoud, Lee, Hyungseok, Zhang, Yuanwei, Wang, Chao, Liu, Zhuang, Chan, Emory M., Duan, Chunying, and Han, Gang. Amplifying the Red-Emission of Upconverting Nanoparticles for Biocompatible Clinically Used Prodrug-Induced Photodynamic Therapy. United States: N. p., 2014. Web. doi:10.1021/nn505051d.
Punjabi, Amol, Wu, Xiang, Tokatli-Apollon, Amira, El-Rifai, Mahmoud, Lee, Hyungseok, Zhang, Yuanwei, Wang, Chao, Liu, Zhuang, Chan, Emory M., Duan, Chunying, & Han, Gang. Amplifying the Red-Emission of Upconverting Nanoparticles for Biocompatible Clinically Used Prodrug-Induced Photodynamic Therapy. United States. doi:10.1021/nn505051d.
Punjabi, Amol, Wu, Xiang, Tokatli-Apollon, Amira, El-Rifai, Mahmoud, Lee, Hyungseok, Zhang, Yuanwei, Wang, Chao, Liu, Zhuang, Chan, Emory M., Duan, Chunying, and Han, Gang. Thu . "Amplifying the Red-Emission of Upconverting Nanoparticles for Biocompatible Clinically Used Prodrug-Induced Photodynamic Therapy". United States. doi:10.1021/nn505051d. https://www.osti.gov/servlets/purl/1257361.
@article{osti_1257361,
title = {Amplifying the Red-Emission of Upconverting Nanoparticles for Biocompatible Clinically Used Prodrug-Induced Photodynamic Therapy},
author = {Punjabi, Amol and Wu, Xiang and Tokatli-Apollon, Amira and El-Rifai, Mahmoud and Lee, Hyungseok and Zhang, Yuanwei and Wang, Chao and Liu, Zhuang and Chan, Emory M. and Duan, Chunying and Han, Gang},
abstractNote = {A class of biocompatible upconverting nanoparticles (UCNPs) with largely amplified red-emissions was developed. The optimal UCNP shows a high absolute upconversion quantum yield of 3.2% in red-emission, which is 15-fold stronger than the known optimal β-phase core/shell UCNPs. When conjugated to aminolevulinic acid, a clinically used photodynamic therapy (PDT) prodrug, significant PDT effect in tumor was demonstrated in a deep-tissue (>1.2 cm) setting in vivo at a biocompatible laser power density. Furthermore, we show that our UCNP–PDT system with NIR irradiation outperforms clinically used red light irradiation in a deep tumor setting in vivo. This study marks a major step forward in photodynamic therapy utilizing UCNPs to effectively access deep-set tumors.Lastly, it also provides an opportunity for the wide application of upconverting red radiation in photonics and biophotonics.},
doi = {10.1021/nn505051d},
journal = {ACS Nano},
number = 10,
volume = 8,
place = {United States},
year = {2014},
month = {9}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 107 works
Citation information provided by
Web of Science

Save / Share:

Works referencing / citing this record:

Direct optical lithography of functional inorganic nanomaterials
journal, July 2017


Prospects For Application of Upconversion Particles NaYF4:Er,Yb for Phototherapy [ПЕРСПЕКТИВЫ ПРИМЕНЕНИЯ АПКОНВЕРСИОННЫХ ЧАСТИЦ NaYF4:Er,Yb ДЛЯ ФОТОТЕРАПИИ]
journal, January 2018